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Lactic acid bacteria are generally believed to have positive roles in maintaining good health and
immune system in humans. A number of Lactobacilli spp. are known to produce important
metabolites, amongwhich biosurfactants in particular have shown antimicrobial activity against
several pathogens in the intestinal tract and female urogenital tract partly through interfering
with bioﬁlm formation and adhesion to the epithelial cells surfaces. Around 46 reports are
documented on biosurfactant production from Lactobacillus spp. of which six can be broadly
classiﬁed as cell free biosurfactant and 40 as cell associated biosurfactants and only
approximately 50% of those have reported on the structural composition which, in order of
occurrence were mainly proteinaceous, glycolipidic, glycoproteins, or glycolipopeptides in
nature. Due to the proteinaceous nature, most biosurfactant produced by strains of Lactobacillus
are generally believed to be surlactin type with high potential toward impeding pathogens
adherence. Researchers have recently focused on the anti-adhesive and antibioﬁlm properties of
Lactobacilli-derived biosurfactants. This review brieﬂy discusses the signiﬁcance of Lactobacilli-
derived biosurfactants and their potential applications in various ﬁelds. In addition, we highlight
the exceptional prospects and challenges in fermentation economics of Lactobacillus spp.-derived
biosurfactants’ production processes.
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Introduction
Probiotic lacticacidbacteriahavean importantrole inmost
dairy-based fermentation processes and Lactobacillus is one
of its most important genera [1]. Lactobacillus spp. together
with Streptococcus are often used in combination in many
dairyproducts for theiracidandﬂavorproductioncapacity.
It is important to note that both of this bacterial spp. are
knowntodisplaceadheringuropathogenicbacteria suchas
Enterococcus faecalis from hydrophobic and hydrophilic
substrata in a parallel-plate ﬂow chamber which may be
through biosurfactant/s production [2]. We are mostly
concerned with the safe role of the genus Lactobacillus in
relation to food and health issues. Among several
metabolites, the food industries have extensively exploited
the usage of lactic acid produced by Lactobacilli strains [3].
It is important, however, to emphasize that not all
Lactobacilli strains are beneﬁcial and harmless; some
may be infective in patients suffering from human
immunodeﬁciency virus [4].
Members of the Lactobacilli spp. have been long
known as one of the potential biosurfactant producers
although their biosurfactant products have not been
completely characterized. A multi component mixture
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with various proportions of protein and polysaccharides-
based biosurfactant with exceptional medical applica-
tions has been reported [2, 5–7]. In addition to
biomedical application considerations, the biosurfac-
tants have been utilized for biodegradation of polluting
hydrocarbons. For example, Thavasi et al. [8] reported
biosurfactant production by L. delbrueckii cultured on
peanut oil cake up to 5.35mgml1 where the bio-
surfactant product is used for bioremediation purposes
and authors also reported enhanced emulsiﬁcation with
biodegradation potential of hydrocarbon pollutants.
Even in the crude form of extracts, the lactic acid
bacteria derived biosurfactants certainly ﬁnd suitability
for environmental applications.
Several review papers have discussed Lactobacilli spp.
for their potential biomedical applications while few
articles converse for lactic acid bacteria originated
biosurfactants production with structural details. The
work combining Lactobacilli producing biosurfactants
with their biomedical potential has not been adequately
reported in literature. However, this is the ﬁrst review
article discussing the complete chemical composition
wise details on Lactobacillus-derived biosurfactants. In
this review, we endeavor to highlight possible advan-
tages and beneﬁts of biosurfactant producing Lactoba-
cilli strains in some products and technologies.
Biosurfactant producing Lactobacilli spp.
Lactobacilli are known to produce a variety of metabolic
by-products in addition to biosurfactants, some of which
have antimicrobial activity including lactic acid, hydro-
gen peroxide, bacteriocins, and bacteriocin-like sub-
stances (Fig. 1) which has imperative medical-related
advantages [9]. Biosurfactants for example can play a
crucial role in reducing the adherence capacity of several
pathogens which is a necessary step for bioﬁlm
proliferation and formation [10]. Antimicrobial activities
and ability to interfere with pathogens adhesion to the
urogenital and intestinal tracts epithelial cells leads to
an ability to act as antibioﬁlm agent. Such bioﬁlms are
quite common on surgical wounds, silicone-based
devices [11], catheters, intravenous catheters, and
cardiac devices and other prostheses [12, 13]. Studies
carried out by Gan et al. [14] highlighted the utility of
Lactobacilli and its biosurfactant in the prevention of
surgical implant infection in vivo.
Detailed studies on several mechanisms of interfer-
ence of pathogen adherence and biosurfactant have
been previously reported by several researchers
[15–18]. The mechanism of competitive exclusion
has been demonstrated by quite a lot of Lactobacilli
spp. where their surface protein namely the
co-aggregation-promoting factor (Cpf) mediates
co-aggregation with the human pathogenic micro-
organisms. This co-aggregation mechanism inhibits
the adherence of pathogens to the epithelial cells of
the host tissue effectively creating a barrier that
prevents colonization by pathogens [19]. Auto-
aggregation of probiotic strains is obligatory for
adherence to epithelial cells and surfaces of mucus,
which consequently supports their accumulation and
growth in those environments. This phenomenon has
been well documented by studies mostly carried out in
oral cavity and the urogenital tract [20].
“Biosurfactants” are products known to reduce
surface tension and interfacial tension and to have
activity at interfaces. Numerous classes of biosurfac-
tants have so far been described according to their
chemical structure, producing strain and mode of
action [21]. At present, we are aware of several potential
Figure 1. Secretion of various antimicrobial compounds by Lactobacilli cells.
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applications of biosurfactants in the surfactant indus-
try [22]. Glycolipids, lipopeptides, protein-like substan-
ces, phospholipids, fatty acids, and lipopolysaccharide
produced by Lactobacilli spp. have been characterized
by several researchers [23–25]. About 46 research
outputs reported Lactobacilli spp. biosurfactant pro-
duction, 6 of which are cell free biosurfactant and 40
cell associated biosurfactant. Based on the preliminary
studies, two reports including Ceresa et al. [11] and
Fracchia et al. [26] have proposed the presence of cell
free biosurfactant as multi-component complex that
can show presence of sugar moieties while single report
by Thavasi et al. [8] describes a glycolipid-type cell free
biosurfactant. The other three research articles avail-
able on cell free biosurfactant without revealing much
speciﬁcation on chemical characterization [27–29].
In comparison, among the 40 cell associated bio-
surfactant reports, about half (50%) do not disclose any
structural details most likely due to the complex
structures that are difﬁcult to elucidate. It is important
to highlight that surlactin/and or proteinaceous cell
associated biosurfactant (32.5%) appears to be most
frequently produced by Lactobacilli spp. Glycolipid (5%)
type of biosurfactants are also produced from probiotic
bacterial cultures [24, 30]. Few reports mentioned
glycoproteins (7.5%) [23, 31, 32] and glycolipopeptide
(5%) production [25, 33].
Most of the focus for cell associated biosurfactant
usage appears toward their anti-adhesive and anti-
bioﬁlm activities [12, 34]. Few reports do mention their
antimicrobial activity of cell associated biosurfactant
[15, 16, 35]. Recently, we have discussed the general
role of several biosurfactants molecules in bioﬁlms
formation and inhibition [10, 36]. Biosurfactants
molecules offer many advantages over synthetic
surfactants including biodegradability and lower
toxicity which makes them supreme candidates for
various biomedical applications [21, 37–40]. Their
great diversity offers varying properties leading to a
number of different applications in various ﬁelds
[39, 41–46]. Biosurfactant support the microbial
entities to grow on hydrophobic or water-immiscible
substrates through various mechanisms like lowering
the surface tension and interfacial at the phase
boundary [43]. Other properties such as wetting,
foaming, emulsiﬁcation affects the adhesion of micro-
bial cells to the organic substrates. A wide variety of
Lactobacilli spp. produces varied types of biosurfac-
tants substances as presented in Table 1.
To date a large number of researchers have investi-
gated biosurfactant producing Lactobacilli spp. includ-
ing L. casei sub spp. rhamnosus 36 and ATCC 7469,
L. fermentum B54 and L. acidophilus RC14. These strains
produce biosurfactants during their mid-exponential
(4–5h) and stationary growth phases (18h) lowering
surface tension [5]. The role of such biosurfactants by
Lactobacilli in their natural environment appears to be
mainly related to the reduction of adhesion of numerous
uropathogens to epithelial cells [9]. Biosurfactants have
also been used frequently against microbes and infec-
tions in the urinary, vaginal, gastrointestinal tracts, and
skin [15]. Often the activity of biosurfactant is mostly
related to an inhibition of pathogen adhesion rather
than a direct antimicrobial activity or inhibition of the
cell growth [48]. Anti-adhesive properties of biosurfac-
tants have a signiﬁcant role in preventing the adhesion
of pathogenic bacteria [34] in addition to the rate of
bacterial deposition as well as bioﬁlm development [32,
54]. Biosurfactants also have a great potential in
preventing microbial colonization on food contact
surfaces [24, 55, 56] and also used in the formulations
from food-based industry to reduce pathogens adhesion
to human epithelial cell receptors [49].
It should be noted that the composition of protein and
polysaccharide fractions of glycoproteins biosurfactant
from Lactobacilli are affected by the composition of the
medium, time, pH, temperature of incubation, inocu-
lums volume, and the growth phase of bacteria [47].
Yeast extract is essential for bacterial growth, while
peptone is crucial for biosurfactant synthesis. Gudi~na
et al. [17] stated that the use of peptone andmeat extract
yields a higher production as compared to the standard
medium like de Man, Rogosa, and Sharpe medium [57].
The presence of magnesium and manganese were also
reported to be essential for bacterial growth and
surlactin (protein rich biosurfactant produced by
Lactobacilli spp.) production [26]. Other environmental
parameters like pH, temperature also determines the
activity of biosurfactant [16]. The de Man, Rogosa, and
Sharpe medium has been usually used for growth and
production of various types of biosurfactants from
Lactobacilli spp.
Proteinaceous biosurfactants have high binding afﬁn-
ities to the various materials such as catheters, medical
devices [5, 6]. It is also important to note that factors
other than biosurfactant do interfere with uropatho-
genic bioﬁlm formation [44]. Lactobacillus spp.-derived
biosurfactant can also inhibit bioﬁlm formed by Candida
albicans [11, 26]. Recent report on the biosurfactant
derived from L. brevis isolate (CV8LAC) has proved its
effectiveness as an anti-adhesive product for several
medical devices such as catheters, stents, and prosthesis
leading to the reduced colonization and prevention of
C. albicans infections [11].
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Table 1. Brief description on types, production, and characterization of Lactobacilli-derived biosurfactants along with their potential
applications.
Lactobacilli spp. Type of biosurfactant (BS)
Production and
characterization Potential application Ref.
 L. acidophilus RC14
 L. casei 70
 L. casei subsp, rhamnosusGR-1
RC14 and B54 produce BS rich
in protein and less content of
polysaccharide, phosphate
 Freeze-drying
 FTIR
 X-ray PS
Protein like BS from
B54 and RC14
effectively inhibit the
adhesion of E. faecalis
to glass surface
[5]
 L. plantarum RC6 & RC20
(isolated from urogenital
tract of healthy woman)
 L. casei subsp. rhamnosus 36
(isolated from awomanwith
a history of urogenital
infections)
36 and B54 produce BS rich in
protein with phosphate,
polysaccharide, presence of
ester carbonyl group
 L. acidophilus T13, L. fermen-
tum B54 (poultry isolate)
 L. casei subsp, rhamnosus 81
(dairy isolate)
All 15 Lactobacillus isolates
produce protein like BS in
mid-exponential and
stationary growth phase
 L. casei subsp., rhamnosus 36
(isolated from awomanwith
a history of urogenital
infections)
Surlactin: the protein rich BS,
shows the presence of
lipoteichoic acid with
molecular weight from 14.4 to
>94 kDa
 Freeze-drying
 FTIR
 X-ray PS
 AAA
 SDS–PAGE
Protein rich BS that
may interfere with
uropathogen
adhesion
[6]
 ATCC 7469 (American Type
Culture Collection)
 L. fermentum B54 (poultry
isolate)
 L. acidophilus RC14 (isolated
from urogenital tract of
healthy woman)
 L. acidophilus RC14 Surlactin: the protein rich BS  Centrifugation
 Filtration
 Dialysis
Inhibit initial
adhesion of
uropathogenic E.
faecalis. Important for
development of anti-
adhesive biological
coatings for catheter
[2]
 L. acidophilus R14 Surlactin: protein,
polysaccharides possibly
bound to phosphate groups
 Centrifugation
 Filtration
 Dialysis
Inhibit initial
adhesion of few
uropathogens
[7]
 L. fermentum RC-14 Composition not stated  Centrifugation
 Filtration
 Dialysis
Inhibit adhesion of
E. faecalis and other
urophathogens
[42]
 L. fermentum B54 Produce anti-adhesive,
proteinaceous BS
Not stated Inhibit initial
adhesion of E. faecalis
[43]
 L. rhamnosus 36 Do not release anti-adhesive
BS
Not stated
(Continued )
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Table 1. (Continued)
Lactobacilli spp. Type of biosurfactant (BS)
Production and
characterization Potential application Ref.
 L. rhamnosus ATCC 7469T
(American Type Culture
Collection)
Do not release anti-adhesive
BS
Not stated
 L. fermentum RC-14
 L. casei Shirota
 L. rhamnosus GR-1
 L. rhamnosus GR-36
Number of collagen-binding
proteins in the crude BS
 Centrifugation
 Filtration
 Dialysis
 Lyophilization
 SELDI WCX-1 Protein Chip
technology
 Collagen cross-linked PS-1
Protein Chip arrays
 AAA
Surface-enhanced
laser desorption/
ionization (SELDI) –
Protein – Rapid
characterization of
proteins and protein–
protein interactions
[44]
 L. fermentum RC-14
 L. rhamnosus GR 1
Composition not stated • Filtration Inhibit implant
infections caused by
S. aureus
[14]
 L. casei CECT-5275 Crude BS •Centrifugation L. pentosus CECT-4023,
strong BS producer,
Cheese whey –
alternative medium
for BS production
[13]
 L. rhamnosus CECT-288 Composition not stated •Extraction
 L. pentosus CECT-4023
 L. coryniformis subsp. Torquens
CECT-25600 (Obtained from
the Spanish Collection of
Type Cultures, Valencia,
Spain)
 L. fermenti 126
 L. acidophilus PG 8/4
 L. rhamnosus CCM 1825
Composition not stated • Centrifugation Anti-adhesive
property
[45]
 L. acidophilus H-1
 L. acidophilus 336
 L. acidophilus Ch-2 Rhodia
Food (Biolacta Company,
Olsztyn, Poland)
Glycoprotein type: the protein
content 8.7mg (LAA H-1),
4.5mg (LAA 336), 9.1mg (LAA
Ch-2), per g of dry mass
 Dialysis
 Freeze-drying
Inhibitors of S. aureus,
S. epidermidis adhesion
and bioﬁlm
development
[34]
 L. casei 8/4 (A culture collec-
tion of the Department of
Industrial and Food Microbi-
ology, University of Warmia
and Mazury in Olsztyn,
Poland)
Glycoproteins with additional
phosphoric groups
 Centrifugation
 Filtration
 Dialysis
 FTIR
 NuPAGE electrophoresis
Exhibit antimicrobial
properties may be
applied in food stuffs,
which is likely to
result in a reduction
of pathogenic
microﬂora count
[32]
 L. paracasei ssp. paracasei A20
(Portuguese dairy plant,
Portugal)
Crude BS
Composition not stated
 Membrane
 Filtration
 Freeze-drying
Antimicrobial and
anti-adhesive
[15]
(Continued )
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Table 1. (Continued)
Lactobacilli spp. Type of biosurfactant (BS)
Production and
characterization Potential application Ref.
 L. paracasei ssp. paracasei A20
(Portuguese dairy plant,
Portugal)
Crude BS
Composition not stated
 Centrifugation
 Membrane ﬁltration
 Dialysis
 Freeze-drying
Antimicrobial, anti-
adhesive activities
against several
pathogens
[16]
 L. acidophilus (Vaginal swabs
of healthy women, Kamal
Al-Samaraei and Al-Alweia)
(Maternity Hospitals in
Baghdad)
Surlactin: glycoprotein
Molecular weight 60–80kDa
 Centrifugation
 Membrane ﬁltration
 Gel ﬁltration
 Dialysis
 Freeze-drying
Crude surlactin in
stationary phase of
growth. Highly stable
at pH 6 and high
temperature
conditions
[47]
 Lactobacillus spp. CV8LAC
(Fresh fruits and vegetables
Italy)
Mixture of various
components including
presence of sugar
 Filtration
 Ultraﬁltration
 TLC
The anti-adhesive
properties against C.
albicans bioﬁlm
[26]
 L. paracasei ssp. paracasei A20
 L. plantarum A14 (Portuguese
dairy plant)
Composition not stated  Centrifugation
 Supernatant
 Extraction
L. paracasei ssp.
paracasei A20 as a
promising BS-
producer
[17]
 L. fermenti 126
 L. rhamnosus CCM 1825 (Cul-
ture Collection of the Chair
of Industrial and Food Mi-
crobiology (CCCIFM)), (Uni-
versity of Warmia and
Mazury (UWM)) in Olsztyn,
Poland
Protein, polysaccharide and
phosphate in different ratio
 FTIR
 Capillary gel electrophoresis
Good anti-adhesive
properties against
Enterobacteriaceae
[48]
 L. delbrueckii (Marine waters,
Tuticorin Port, Tamil Nadu,
India)
Glycolipid with carbohydrate
and lipid combination of
30%:70% (w/w)
 FTIR
 MS
BS alone can promote
biodegradation to a
large extent without
adding fertilizers
[8]
 L. acidophilus Leibniz Insti-
tute DSMZ-(German Collec-
tion of Microorganisms and
Cell Cultures)
Protein-like component with
presence of polysacchardies
and phosphate fractions
 Centrifugation
 Filtration
 Dialysis
 FTIR
Interfere in the
adhesion, bioﬁlm
formation of the
S. mutans to glass
[49]
10 Lactobacilli species
(traditional Egyptian dairy
products collected from the
CairoMarkets, Egypt)
Crude BS: composition not
stated
 Centrifugation
 Acidiﬁcation
 Extraction
 Evaporation
Distinct
antimicrobial, anti-
adhesive activities
against pathogens
[35]
 L. pentosus Mostly protein rich fraction • Not stated The adsorption
properties of BS onto
sediments present it
as a potential foaming
agent in froth
flotation
[50]
(Continued )
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Table 1. (Continued)
Lactobacilli spp. Type of biosurfactant (BS)
Production and
characterization Potential application Ref.
 L. pentosus CECT-4023 T
(ATCC-8041) (Spanish Collec-
tion of Type Cultures
Valencia, Spain)
Glycoproteins, or
glycolipopeptide
 Centrifugation
 Filtration
Bioremediation of
hydrocarbon-
contaminated soil
[25]
 L. plantarum CFR 2194 (Iso-
lated from kanjika, rice-
based ayurvedic fermented
product)
Glycoprotein – protein,
polysaccharide fractions
 Centrifugation
 Filtration
 Dialysis
 Freeze-drying
Anti-adhesive
property against food-
borne pathogens
[23]
 Lactobacilli strain Glycolipid (lipid and sugar
fractions) closely similar to
xylolipids
 Centrifugation
 Filtration
 Gel ﬁltration
 Dialysis
 Freeze-drying
 FTIR, NMR
 TGA
Proposed application
of BS for oral
consumption and
biomedical
applications
[24]
 L. casei MRTL3 (raw milk) Glycolipids – mixture of lipid
and sugar
 Centrifugation
 TLC, FTIR
 NMR
Antibacterial against
8 cultures
[30]
 L .jensenii
 L. rhamnosus
Composition not stated  TEM Antimicrobial, anti-
adhesive, anti-bioﬁlm
activities against
A. baumannii, E. coli, S.
aureus
[51]
 L. rhamnosus (isolated from
vagina of Iraqi healthy
women was studied)
Crude biosurfactant  Centrifugation
 Acidiﬁcation
 Extraction
 Evaporation
Inhibitory effect on
adherence and
bioﬁlm formation of
E. coli, S. aureus, K.
pneumoniae, B. cepacia
[29]
 L. reuteri DSM20016 (Probi-
otic source)
Cell associated BS
Composition not stated
 Centrifugation
 Cell collection
 Resuspension
 Supernatant
 Filtration
 Dialysis
 Freeze-drying
Inhibitor of the
glucosyltransferases and
fructosyltransferase
strain of
S. mutans (ATCC35668)
affect initial adhesion
to the tooth surface
[52]
 L. pentosus Cell associated
glycolipopeptide type
composed of C:18 and C:16
fatty acids
 Centrifugation
 Extraction
Higher emulsion
volumes and stable
emulsions than
polysorbate 20
[33]
 L. brevis CV8LAC (fresh cab-
bage obtained from a pro-
ducer of biological fruit,
vegetables in a rural area
of Piedmont, Italy)
BS with mixture of
components including sugar
as one of the fractions
 Centrifugation
 Acidiﬁcation
 Extraction
 Evaporation
Inhibition of adhesion,
bioﬁlm formation ofC.
albicans on medical-
grade silicone
elastomericdisk (SEDs)
[11]
(Continued )
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Lactobacilli lipopeptides – composition,
chemical structures, and mechanisms of
action
It is well known that biosurfactant molecules can be
quite complex and often composed of carbohydrates,
proteins, and lipids mixtures. To date, glycolipids,
glycolipopeptide, glycoprotein with or without addi-
tional phosphoric groups have been reported to be
produced by Lactobacilli’s thorough utilizing the several
analytical techniques such as Fourier transform infrared
spectroscopy, nuclear magnetic resonance (1H and 13C),
gas chromatography mass spectrometry (GC-MS), liquid
chromatography-mass spectrometry (LC-MS), high per-
formance liquid chromatography (HPLC) among others.
From the literature survey, it appears that protein-based
biosurfactants has been reported very frequently from
Lactobacilli spp. in comparison with glycolipopeptide/
glycolipoprotein. Often the hydrophobic chain of bio-
surfactant is composed of lipids, whereas the hydro-
philic chain is mostly composed of proteins or sugar
moieties conferring unique properties. Sometimes the
biosurfactant molecules are complex and difﬁcult to
determine, see Table 1 for common biosurfactants
produced by Lactobacilli strains. Many such complex
structures have been reported for either anti-adhesive,
antibioﬁlm, or as antimicrobial agents against several
pathogenic strains. Currently, cell free biosurfactant
(only 13% reports available) and cell associated bio-
surfactant (87% reports) have been obtained from
Lactobacilli spp.
The success story of surlactin
Researchers have classiﬁed biosurfactants broadly as low
molecular weight (glycolipids, short chain containing
lipopetides) and high molecular weight (bioemulsiﬁer-
based polymeric and lipopeptides). Among which
rhamnolipids and surfactin represents the most exten-
sively characterized low molecular weight biosurfac-
tants. Production of rhamnolipid (due to the presence of
rhamnosemoiety) from Pseudomonas pyocyanea (currently
known as P. aeruginosa) was documented by Bergstr€om
et al. [58]. Since 1968 surfactin (term coined due to strong
surfactant activity greater than synthetic surfactant
namely sodium lauryl sulphate), a crystalline lipopep-
tide-type biosurfactant which is routinely isolated from
cell free supernatant produced by Bacillus subtilis [59].
Today, rhamnolipid and surfactin have been widely
exploited for various industrial purposes. Initially, all
surfactin compounds were considered as antimicrobial
agents which later on subsequent studies proved them as
surface active agents. Similarly, about in mid-1990s
Table 1. (Continued)
Lactobacilli spp. Type of biosurfactant (BS)
Production and
characterization Potential application Ref.
 L. agilis CCUG31450 Glycoprotein  Centrifugation
 Filtration
 Gel ﬁltration
 Dialysis
 Freeze-drying
 FTIR
Anti-adhesive activity
against
S. aureus, and
antimicrobial activity
against S. aureus,
S. agalactiae, P.
aeruginosa
[31]
 L. acidophilus ATCC 4356 Proteinaceous BS with
presence of polysaccharides
and phosphate fractions
 Centrifugation
 Filtration
 Gel ﬁltration
 Dialysis
 Freeze-drying
 FTIR
The inhibitory effect
on bioﬁlm forming S.
marcescens
[46]
BS, biosurfactant; FTIR, Fourier transform infrared spectroscopy; HPLC, high performance liquid chromatography; AAA, amino
acid analysis; MS, mass spectroscopy; NMR, nuclear magnetic resonance; TGA, thermal gravimetric analysis; TLC, thin layer
chromatography; ASP, ammonium sulphate precipitation; X-ray PS, X-ray photoelectron spectroscopy; TEM, transmission electron
microscopy.
Note: Information available on the chemical structure of biosurfactants produced by genus Lactobacilli is not adequate.
Researchers, namely, Velraeds et al. [2, 5–7, 43], Howard et al. [44] demonstrated biosurfactant production from Lactobacillus
strains which were isolated previously by Reid et al. [53].
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researchers started hunting for health associated
beneﬁts of lactic acid bacteria, probiotics and their
metabolites. The biosurfactants produced by Lactobacilli
spp. are believed to interfere the pathogenicity confer by
microbes through different mechanisms, where it is
believed that biosurfactant plays a critical role [12]. The
equation like rhamnolipid only from Pseudomonas spp.,
surfactin type only from Bacillus spp., and surlactin type
only from Lactobacillus spp. can be considered
authentically.
Velraeds et al. [5] started talking about biosurfactant
from various Lactobacilli strains where L. acidophilus
exhibited production of protein rich cell associated
biosurfactant with presence of small fractions of
polysaccharides and phosphates. Parallel studies
reported by same researchers [6] coined the terminology
namely “Surlactin” for the ﬁrst time. They described the
surlactin as a protein rich cell associated biosurfactant,
released by speciﬁc strains of Lactobacillus spp. during
stationary phases and enough competent to interfere the
adhesion of uropathogens. Further contribution in the
subsequent year by same researchers [2] could demon-
strate the inhibitory effect of L. acidophilus-derived
surlactin-type biosurfactant against uropathogenic
E. faecalis on silicone-based surface rather than glass
surface. Subsequently, fourth report appeared from
research group of Velraeds et al. [7] conﬁrmed the role of
“surlactin” obtained from L. acidophilus RC14 for inhibi-
tion of initial adhesion of uropathogens in addition to
two yeast strains on silicone rubber. Surlactin again
proved to have a marked inhibitory effect against tested
pathogens including both strains of Candida. From the
overview of literature, it is imperative to emphasize that
greatest contribution about surlactin is put forward by
the authors from Velraeds research group.
In the year 2010, Fouad and coworkers [47] described
the surlactin as a glycolipoprotein complex produced
using L. acidophilus. Authors characterized glycolipopro-
tein with a molecular weight of 60–80 kDa through gel
ﬁltration studies and also highlighted that presence of
magnesium (0.04%) and manganese sulfate (0.01%) are
essential for the growth of the strain as well as for the
production of surlactin.
An interesting piece of work is contributed by Munira
and coworkers [60] on surlactin derived from
L. acidophilus using different strains. Authors have
commented that different strains of Lactobacilli produce
varied type of surlactin and therefore, it is obvious to
behave differently to display the mechanism of action.
Their efforts were toward investigating the biological
applications of surlactin to inhibit the adhesion of
bioﬁlm forming pathogenic strain like P. aeruginosa on
contact lenses. Their results demonstrated the capability
of surlactin to inhibit the adhesion of pathogens up to
60% without any antibacterial activity. The surlactin
proved to be effective for treating the infection in
rabbits’ eyes with P. aeruginosa. Furthermore, their
studies also proved that infection with P. aeruginosa
(administrated to rabbits’ eyes) can be prevented by
using surlactin. However, no satisfactory results were
found against Staphylococcus aureus culture. Recent
studies appeared from Vecino et al. [50] proved the
chemical composition of surlactin through using
analytical techniques like Fourier transform infrared
spectroscopy, to indicate presence of protein rich
fractions.
Overall cell associated biosurfactant produced by
certain Lactobacilli strains having high proteinaceous
(could be a complex of glycoprotein or glycolipoprotein)
can be claimed as surlactin-type biosurfactant. Based on
Velraeds et al. [2] terms and observation, a deﬁnition for
surlactin is advised by Fouad et al. [47] claiming that
surface active agents produced by Lactobacillus strains or
surface lactin. The fact that the term surlactin is
appeared due to the complexity in chemical structure
which can be compared with mucoproteins which has
abilities to adhere to the surfaces. Few researchers have
reported cell associated biosurfactant as a combination
of proteins with the presence of sugar or lipid moieties.
However, we shed a light suggesting that there are
researchers who have not used the terminology
“surlactin” for biosurfactant isolated by them instead
they described only as proteinaceous-type biosurfac-
tant [46, 48, 49].
Biosurfactant obtained from cell free supernatant
Most of the low molecular weight biosurfactants of
microbial origin (rhamnolipid, surfactin, cyclic lipopep-
tides, iturins, fengycins) have been reported to be
released extracellularly, and have occupied global
market including, transplantation, devices manufactur-
ing units. Handling of these compounds for commercial
purposes seems to be uncomplicated where many
coating formulations have been designed to protect
implant materials. Closer observation on available
literature about genus Lactobacillus put forward that
secretion of cell free biosurfactant is not reported much
frequently. Chemical composition wise, generally cell
free biosurfactant from a small number of Lactobacillus
spp. are produced as mixture of various compounds,
however, distinct work contributed by Thavasi et al. [8]
suggests that cell free biosurfactant can be of glycolipid
type. They reported production of cell free biosurfactant
L. delbrueckii of having a combination of carbohydrate
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(30%) and lipid (70%) evident through Fourier transform
infrared spectroscopy analysis suggesting the presence
of signiﬁcant bands at 2962, 2924, and 2854 cm1 (for the
CH aliphatic stretching), 1061 cm1 (PII band: polysac-
charides), 1793 cm1 (for the C55O ester bond), 3388 and
3696 cm1 (for OAH bonds), and 766, 700 cm1(for the
CH2 group). The overall analytical observations illus-
trated the presence of different fractions in biosurfac-
tant which can be claimed as glycolipid type. Mass
spectroscopic analysis (m/z¼ 326.5 and at 663.4 for lipid
and glycolipid moieties) also conﬁrm the data obtained
by Fourier transform infrared spectroscopy.
Even though, cell free biosurfactant possessing the
mixture of various components (including sugars) do
have a noteworthy key role in biomedical applications.
Studies by Ceresa et al. [11] demonstrated the production
of cell free biosurfactant (structure not determined)
from L. brevis (CV8LAC) which prevents the adhesion of
C. albicans on medical-grade silicone elastomeric disks.
Thus authors have proved cell free biosurfactant as
hopeful aspirant for biomedical approaches. At a
concentration of 2000mgml1, cell free biosurfactant
also reduced bioﬁlm formation by C. albicans by 89 and
90% after 24 and 72h of incubation. Similarly, Fracchia
et al. [26] reported on the antibioﬁlm activity of CV8LAC
cell free biosurfactant against Candida cultures which
has many appealing applications.
Augustin and Hippolyte [27] characterized cell free
biosurfactant (without any structure details) from
Lactobacillus spp. which was isolated from pendidam, a
fermented milk product (local brand, Ngaoundere,
Cameroon). The strain TM1 showed biosurfactant
production potential in drop collapse (7.30mm of
diameter), best emulsiﬁcation ability (56.80%), and also
good reduction in interfacial tension values (45.09 mN/
m). The cell free biosurfactant obtained also has broad
spectrum of antimicrobial activity against bacterial
strains like Escherichia coli, B. cereus, Salmonella spp., and
E. faecalis. Augustin and Hippolyte [27] proposed that
antimicrobial activity of cell free biosurfactant repre-
sents as excreted factors and not as cell associated or cell
surface components. No loss in the activity of cell free
biosurfactant even after treatment at different condi-
tions and therefore such surface active substances can be
utilized in food preservation procedures to prevent their
spoilage. On similar background, in the succeeding year,
Augustin et al. [28] again reported cell free biosurfactant
(no composition revealed) production from three strains
of Lactobacillus spp. and showed good stability over a wide
range of pH (6.0–12.0) and salinity (5.0–15.0%). The cell
free biosurfactant have huge potential for their antibac-
terial activities. Salman and Alimer [29] conducted
experimental work to compare the cell free biosurfac-
tant in crude and partially puriﬁed cell free biosurfac-
tant to check the inhibitory effect against urinary tract
infection causing bacteria like K. pneumonia, S. aureus, and
B. cepacia. The researchers suggested that surface activity
of cell free biosurfactant is good when it is in the crude
form to impede the adherence as well as bioﬁlm formed
by those pathogenic bacteria.
Cell bound or associated biosurfactant
Proteinaceous composition. Many antibiotics, antimi-
crobial agents do possess protein as one of the major
functioning fractions of the entire molecule. The
proteinaceous nature or peptides do contribute toward
antimicrobial activity and have tremendous potential for
treating and/or preventing the infectious diseases. Risk
of microbial resistance can be reduced certainly with the
help of such proteinaceous molecules. Protein rich with
and without polysaccharide, phosphate fractions in cell
bound or cell associated biosurfactant originated from
Lactobacillus spp. have undoubtedly fulﬁlled this expec-
tations proving to combat pathogens. Several research-
ers could successfully document the potentiality of cell
associated biosurfactant as antimicrobial, antibioﬁlm,
and anti-adhesive agents.
Velraeds et al. [5, 6] reported on L. acidophilus RC14 and
L. fermentum B54 strains producing proteinaceous rich
biosurfactant where smaller fractions of polysaccharide
and phosphate were also detected using Fourier
transform infrared spectroscopy. Further their work
on other strains namely L. Casei sub spp. Rhamnosus 36
and L. rhamnosus ATCC7469 showed production of
protein, polysaccharide, and phosphate containing
biosurfactant along with additional ester carbonyl
group. The bands detected were at 2932 cm1 (CH
band:CH2─CH3), 1652 cm1 (AmI band:CAO stretching
in proteins), 1537 cm 1(AmII band: NOH bending in
proteins). In addition bands at 1234 cm1(PI band:
phosphates) and at 1066 cm1(PII band: polysaccharides)
were also detected. Velraeds et al. [2] also reported
surlactin-type protein rich biosurfactant from L. acidoph-
ilus RC14 which is a proﬁcient ideal candidate for
developing anti-adhesive biological coatings for catheter-
like medical devices. The same group also reported
protein and polysaccharides bound with phosphate
fraction biosurfactant from L. acidophilus R14 [7].
Recent work by Shokouhfard et al. [46] reports protein
rich containing polysaccharide-type biosurfactant from
L. acidophilus ATCC 4356 which was detected by Fourier
transform infrared spectroscopy analysis. They detected
2929 cm1 (CH band: CH2─CH3 stretching), 1655 cm1
(AmI band: CAO stretching) bands which indicates the
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presence of proteins fractions. Polysaccharides with
phosphate fractions were also conﬁrmed with bands at
1402 cm-1 (AmII band: NOH), 1260 cm1 (PI band:
phosphates) and 1056 cm1 (PII band: polysaccharides).
The authors proposed the predominance of protein in
glycopeptides biosurfactant having anti-adhesive against
bioﬁlms developed by S. marcescens strains.
Brzozowski et al. [48] also reported biosurfactant
production by L. fermenti 126 and L. rhamnosus CCM 1825
having proteinaceous biosurfactant with an existence
of polysaccharide and phosphates biosurfactant
obtained L. rhamnosus CCM 1825 possessed more
proteins and phosphates as compared with L. fermenti
126. The L. fermenti 126 produced biosurfactant had an
excitations at the wavelengths of 3285, 1653, and
1549 cm1, with a typical of stretching bonds >N─H,
CO─N (AmI protein band) and N─H (AmII protein band)
supporting the occurrence of proteinaceous compo-
nents. L. rhamnosus CCM 1825-derived biosurfactant also
shows excitation at similar wavelengths, i.e., 3287,
1656, and1547 cm1. The signal received for biosurfac-
tants from L. fermenti 126 and L. rhamnosus CCM 1825 at
the band of 2964, 2929, and 1458 cm1, and 2961, 2936,
and 1453 cm1, respectively, corresponding to C─H
bonds of ─CH3, ─CH2─, and >CH2 groups of aliphatic
chains. Brzozowski et al. [48] commented that the
occurrence of a polysaccharide fraction in both
biosurfactants is evident in the wavelength range from
1200 to 1000 cm1. While the excitation spectrum at
1078 and 1083 cm1 (PII polysaccharide band) is
representative of bond vibrations in the C─O─C group.
The absorbance at 1237 and 1240 cm1 (PI phosphate
bond) and 935 and 932 cm1 were equivalent to the
stretching bonds formed by phosphorus and oxygen
atoms (P─O─C) in aromatic and aliphatic molecules.
The absorbance coefﬁcients detected for AmI, AmII, PI,
and PII bands, counted as the ratio to the C─H band for
the biosurfactant resulted from L. fermenti 126 which
are equal to 2.0, 1.1, 0.9, and 1.7, respectively. In case of
L. rhamnosus CCM 1825 biosurfactant showed absor-
bance coefﬁcients for bands AmI/CH, AMII/CH, PI/CH,
and PII/CH with higher values of equal to 2.5, 1.4, 1.2,
and 2.1, respectively. Researchers [48] also compared
absorbance coefﬁcients and concluded that minor
differences are present in the chemical structure of
both types of biosurfactants.
Fascinating report on biosurfactant production from
L. fermentum RC-14, L. rhamnosus GR-1 and 36, L. casei
Shirota which contained proteins with a capacity to bind
to both collagen types. These studies byHoward et al. [44]
were supported through surface-enhanced laser desorp-
tion ionization – time of ﬂight mass spectrometry.
Among all three types, biosurfactants from RC-14
predominately indicated the presence of higher number
collagen-binding proteins. With these techniques,
authors tried to report the use of surface-enhanced
laser desorption ionization like system for rapid
characterization of complex biosurfactants solutions.
In the oral cavity, S. mutans is one of the known gram-
positive bacterium predominantly responsible for for-
mation of dental bioﬁlm. The polymers namely glucans
and fructans, an extra cellular polysaccharides facili-
tates the adherence of these cocci-shaped bacteria on
tooth surface. Due to unusual capacity of S. mutans to
adhere on tooth and initiate development of bioﬁlms
ultimately leading to dental caries. The gene cassette
gtfB, gtfC, and gtfD encoding the synthesis of polymer
secretions and therefore, is an impending target for
defence against oral cavity caries [61]. Single attempt is
recorded on this aspect by Tahmourespour et al. [49]
showing the production of protein-like cell associated
biosurfactant from L. acidophilus DSM 20079 which
interferes in the adhesion and also S. mutans bioﬁlm
formation. The cell associated biosurfactant could make
streptococcal chains shorter. Authors tried to verify the
data through real time reverse transcription polymerase
chain reaction (RT-PCR) quantitation and showed the
evidence of decrease in expression of gtfB and gtfC genes
in the presence of cell associated biosurfactant.
Tahmourespour et al. [49] attempted to analyze that
cell associated biosurfactant through Fourier transform
infrared spectroscopy technique pointing out the domi-
nance of protein components with major bands at
2933 cm1 (CH band: CH2─CH3 stretching), 1653 cm1
(AmI band: CAO stretching in proteins), 1480 cm1 (AmII
band: NOHbending in proteins) with 1248 cm1 (PI band:
phosphates) and 1099 cm1 (PII band: polysaccharides).
As a result authors anticipated the presence of protein as
one of the major components in addition to a
polysaccharide and phosphate in the biosurfactant
produced by L. acidophilus. Thus on the basis of their
ﬁndings, cell associated biosurfactant can effectively
hamper with adhesion processes of S. mutans on teeth
surfaces. These studies are momentous to depict the role
of cell associated biosurfactant as antimicrobial, anti-
adhesive, and antibioﬁlm agent and affecting the
expression level of extracellular enzymes of glucosyl
transferases (GTFs) in S. mutans bioﬁlms.
Glycolipid. The production of glycolipid complex
containing carbohydrate (mono or oligo saccharide)
and lipid moiety with surface active properties is widely
accepted in case of Pseudomonas spp. Whereas, in case of
Lactobacillus spp. the majority of the literature appears to
be protein-based biosurfactant. There are few exceptions
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where glycolipid-type biosurfactant obtained from
Lactobacilli spp. Sharma and Singh Saharan [30] used
L. casei MRTL3 as biosurfactant producing strain and
reported glycolipid-type biosurfactant analyzing
through thin-layer chromatographic studies. The pres-
ence of lipid and sugar moieties in biosurfactant was
conﬁrmed using 1H-Nuclear magnetic resonance spec-
troscopy. The presence of methyl esters glycolipid
biosurfactant was correlated to an increased hydropho-
bicity and, as a result enhancing not only the
biosurfactant surface activity but also hemolytic and
antifungal activities. Sharma et al. [24] reported again
glycolipid-type biosurfactant from Lactobacilli spp.
having mixture of sugar and lipid fractions which was
claimed to be similar to xylolipid. Fourier transform
infrared spectroscopy and nuclear magnetic resonance
analysis conﬁrmed the presence of glycolipid with
hexadecanoic fatty acid (C16) chain. Fourier transform
infrared spectroscopy technique has been proved as one
of the most signiﬁcant technique routinely followed to
investigate the functional groups of unknown
compound [30].
Glycoprotein. As mentioned previously in the above
paragraphs, proteinaceous biosurfactants have been
generally reported by Lactobacilli spp. In Fourier
transform infrared spectroscopy analysis, glycoprotein-
type biosurfactant are observed in the typical absor-
bance maxima at wavelengths ranges between 3500 and
1500 cm1 with a characteristic of stretching !N─H
bonds and CO─N and N55O bonds, conﬁrming the
incidence of proteins in the sample under analysis. The
absorption peak around 3000 corresponds to the
presence of bonds occurring in aliphatic chains
(─CH3, ─CH2─). The indication of a spectrum over
wavelength range of 1200–1000 cm1 signiﬁes the
polysaccharide fraction of BS while very strong absorp-
tion at wavelength of 1087.2 cm1 indicates C─O─C
bonds. Recent contribution by Madhu and Prapulla [23]
observed protein and polysaccharide fractions typical of
glycoprotein in BS isolated from L. plantarum CFR 2194.
The Fourier transform infrared spectroscopy revealed a
nonhomogeneous structure consisting of protein and
polysaccharide fractions. Madhu and Prapulla [23] also
suggested that the composition of biosurfactant com-
plex is deﬁnitely affected by the various components
present in the media used in the fermentation process as
well as phase of growth of the biosurfactant synthesizing
organism. Glycoprotein-based biosurfactant extracted
from L. agilis CCUG31450 reduces surface tension of
water to 42.5mNm1, had a critical micelle concentra-
tion (cmc) of 7.5mgml1 with high emulsifying activity
(E24¼ 60%) [31].
Gołek et al. [32] reported on a L. casei 8/4 producing
glycoprotein type BS rich in proteinaceous nature with
polysaccharide as one of the major fractions. A
characteristic Fourier transform infrared spectroscopy
excitation spectra at wavelengths of (1546 and
1653 cm1), (1547 and 1653 cm1), and (1549 and
1655 cm1) conﬁrms protein fractions and excitation
spectra for polysaccharides fraction were detected at
wavelengths of 1066, 1068, and 1073 cm1. The evidence
for phosphoric groups was observed by excitations
spectra that occurred at wavelengths 1236, 1238, and
1240 cm1, respectively. Authors put forward the similar
opinion in agreement with Madhu and Prapulla [23]
explaining the importance of media composition and
growth condition with respect to determination of
structural characteristics of proteins in glycoproteins.
Gołek et al. [32] also reported biosurfactant (without
structure elucidation) from L. fermenti 126, L. acidophilius
PG 8/4, L. casei rhamnosus CCM 1825 and showed their
anti-adhesion activities against Klebsiella pneumonia on
intestinal epithelial cells (using Caco-2 cell line).
Glycolipopeptide. The cell associated biosurfactant
complexes of having chemical composition of glyco-
lipopetide are rarely cited. Since huge structural
complexity is associated with glycolipopetide-type
biosurfactants, very few species of Lactobacilli are
known for their production. Vecino et al. [33] reported
the production cell associated from L. pentosus with a
fatty acid (in hydrophobic chain portion) based compo-
sition including linoelaidic acid, oleic, elaidic acid,
palmitic acid, and stearic acid. The authors proposed
that fatty acid chains in cell associated biosurfactant are
very much similar to the fatty acid containing fractions
detected in rhamnolipid biosurfactant (originated from
Pseudomonas strains). Moldes et al. [25] characterized
glycoprotein or a glycolipopeptide-type biosurfactant
produced from L. pentosus using Fourier transform
infrared spectroscopy analysis showing occurrence of
OH and NH groups, C55O stretching of carbonyl groups
and NH bending (peptide linkage) and also CH2─CH3 and
C─O stretching indicating the presence of lipid frac-
tions. Such characteristic spectra of biosurfactant have
been reported from several lactic acid bacteria.
Cell associated biosurfactant with no structure details.
Literature survey illustrates that themajority of work on
cell associated biosurfactant explored is mainly for their
antimicrobial, anti-adhesive, and antibioﬁlm character-
istics. However, huge basin remains untouched without
revealing the detailed structural and chemical composi-
tion related to cell associated biosurfactant. Basically the
structural complexity may the most probable hindrance
to reveal the unexposed information. Since 1996 up to
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1999, the very limited literature had discussed the
production of BS. In the year of 1999, Reid et al. [42]
added valuable work in this regards. Authors used
L. fermentum RC14 strain for biosurfactant production in
de Man, Rogosa, and Sharpe medium and showed that
those complex molecules can inhibit adhesion of
commonly found uropathogens in female urinary tract.
Velraeds et al. [43] worked with several strains of
Lactobacilli including L. fermentum B54, L. rhamnosus 36,
and L. rhamnosus ATCC 7469T and reported proteinaceous
kind biosurfactant without much elucidation of struc-
tural components. Rodrigues et al. [13] extensively
worked toward media optimization for biosurfactant
production from various Lactobacilli spp.
Walencka et al. [34] also reported a biosurfactant
produced by L. acidophilus (no description of structural
characteristics) which inhibits bioﬁlms development in
S. aureus and S. epidermidis affecting initial adhesion,
bioﬁlm formation, and cells dispersal. It was suggested
that the addition of biosurfactant to preformed mature
bioﬁlms leads to rapid dispersion and alters the
morphological changes of bioﬁlm structures due to
altering cell-surface hydrophobicity of the tested bacte-
ria. This can ultimately hamper the deposition rate as
well as development of bioﬁlm.
Sambanthamoorthy et al. [51] investigated BS produc-
tion by L. jensenii and L. rhamnosus and carried out in vitro
studies on antimicrobial, anti-adhesive, and antibioﬁlm
abilities of the cell-bound BS (structure not described)
against various pathogens such as multidrug resistant
E. coli, S. aureus, and Acinetobacter baumannii. On similar
aspects Gomaa [35] reported cell free biosurfactant and
cell associated biosurfactant production (without any
detailed description) using L. acidophilus, L. brevis, L ruteri.
Researchers namely, Gan et al. [14], Gudi~na et al. [15–17],
Kermanshahi et al. [62], Moldes et al. [54] reported several
Lactobacilli spp. for production of cell free biosurfactant
and cell associated biosurfactant with antimicrobial and
anti-adhesive properties. However, it is important to
note that no structural details are available on those
biosurfactants.
Very few studies have been contributed toward
understanding the role of Lactobacillus-derived BS on
gene expression conferring the virulence properties to
bioﬁlm forming bacteria. For example, Tahmourespour
et al. [49] initiated studies (discussed previously) and
later demonstrated by Salehi et al. [52] indicating the
effects of cell associated biosurfactant puriﬁed from
L. reuteri (DSM20016) on the gene expression proﬁle of
essential adhesion genes (gftB/C and ftf,) in S. mutans
(ATCC35668). The cell associated biosurfactant (struc-
ture not described) has been proved as potential
inhibitor of the glucosyltransferases and fructosyltransferase
in S. mutans (ATCC35668). It is very important to note
that the inhibition is predominantly advantageous due
to its selectivity in action and does not hamper other
microbiota inside the mouth other than S. mutans.
L. rhamnosus-derived crude cell associated biosurfactant
inhibit bioﬁlms produced by potential pathogenic
bacteria viz., S. aureus and P. aeruginosa. Cell associated
biosurfactant work effectively to affect the growth and
antibacterial and anti-adhesive in association with
polyvinyl alcohol–biosurfactant mixture in glass and
plastic plates [52].
Biomedical-related role of Lactobacilli-derived
biosurfactant
One of the main physiological roles of the Lactobacilli
spp. in the gastrointestinal tract is the prevention of the
proliferation of harmful pathogenic bacteria. However,
this may not be true when they are associated with
dental caries [63]. Several Lactobacillus spp. are part of the
human and animal commensal intestinal ﬂora. They are
considered to be protective organisms which prevent the
growth of pathogenic organisms through the production
of lactic acid and other metabolites creating an acidic
environmentwhich inhibits the growth of someharmful
bacteria. Various anti-infective properties of Lactobacilli
spp. are illustrated in Fig. 2.
Isolating members of Lactobacilli can be difﬁcult.
Regular media namely nutrient broth or Luria broths are
commonly used for the growth and maintenance of
bacterial cultures may not usually support the growth of
this genus. Growing Lactobacilli need special nutrient
provision (like de Man, Rogosa, and Sharpe medium) and
sometimes extended incubation periods and members are
likely to get wrongly identiﬁed due to their morphological
resemblance to other bacterial genera such as Corynebacte-
rium,Streptococcus, andClostridium [64]. Even though, species
of Lactobacilli is generally considered to be protective
organisminhealthyhumans, somecritical issuesregarding
potential pathogenicity have been explained in the
immune-compromised patients [4]. Some researchers have
suggested that possible infections can be caused by
Lactobacillus spp. in the acquired immune deﬁciency
syndrome patients having neutropenia or following organ
transplantation [65]. Endocarditis, bacteremia, neonatal
meningitis, dental caries, abscesses, and chorioamnionitis
are all types of clinical infections reported so far by
Lactobacilli [63]. Post-adhesion competitions against uro-
pathogens are the main signiﬁcant features that are
contributed by Lactobacilli. Major inhibitory effects on
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the initial deposition and adhesion of some uropathogens
havebeendemonstratedbyVelraedsetal. [2,5,6].However,
some Lactobacilli spp. may not show initial inhibition of
uropathogenic E. faecalis [65].
Cytotoxicity ultimately leads to loss of cell membrane
integrity resulting in cell lysis or necrosis. Most
biologically produced secondary metabolites such as
antibiotics, polypeptides, proteins, etc. may have cyto-
toxic effects to some extent and have to be tested to
establish suitability for health-related applications. Lack
of cytotoxic effects is therefore important for consider-
ation of application related to human health, from a
safety point of view [24]. Literature suggests that in
addition to antimicrobial, anti-adhesive, and antibioﬁlm
properties, biosurfactant obtained from Lactobacillus spp.
do possess cytotoxic effect. This is supported by Sharma
et al. [24] who investigated the cytotoxic effect of
L. helveticus-derived biosurfactant using a mouse ﬁbro-
blast (ATCC L929) cell line. They reported that as the
concentration of biosurfactant increased (6.25–25mg
ml1) there was a gradual decreased in cell viability. Cell
viability of 30.9% was determined at the concentration
of 25mgml1 and was similar to commonly used
rhamnolipid (as positive control) which showed
32.87% of cell viability at similar concentration.
Sambathammorthy et al. [51] also determined cyto-
toxicity of biosurfactant derived from two strains
L. jensenii and L. rhamnosus using human lung epithelial
cell line (A549). The cytotoxicity of the crude biosurfac-
tant was evaluated in two ways, ﬁrstly by the release of
lactate dehydrogenase and secondly by total cell number
assay. No toxicity was observed at the concentrations of
25–100mgml1 and low toxicity levels were observed at
200mgml1 by both biosurfactant extracts. In conclu-
sion, the limited literature available to this subject
appears to conﬁrm that biosurfactants originated from
Lactobacillus spp. has low cytotoxic effect comparable to
commercially available rhamnolipids which are gener-
ally considered nontoxic products. This makes them
potential safe candidates for use in biomedical applica-
tion particularly as topical delivery products.
Role of low-cost fermentative media in
biosurfactant production
The use of various cheaper renewable substrates such as
distillery wastes, animal fat, molasses, plant oils, oil
wastes, and starchy substances, lactose containing whey
and oil industries are common in the fermentation
industries. Three major aspects are needed to be
considered to increase the biosurfactant production at
commercial scale. The ﬁrst is improvement in the
fermentation technology followed by use of cheaper,
renewable substrates and their continued reliable
supply. Table 2 presents a brief listing of the variety
Figure 2. Illustration of four different ways for anti-infective properties of Lactobacilli spp.
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of suitable cheap raw substrates used in biosurfactants
production. Low yield of biosurfactant at industrial level
is the main problem faced by industries in addition to
the high cost inputs essential to run large scale
fermentations. Usage of renewable substrates could
provide an alternative solution toward advancement of
the process. A variety of renewable substrates that can be
used for large scale production including agro-industrial
waste, animal fat waste, coffee processing residues, dairy
industry, distillery industry industrial efﬂuents, food
processing industry, fruit processing industry, oil
processing mills were all reported [69]. Cheese whey
has been exploited as an alternative medium at
commercial level [70] where L. pentosus CECT-4023
reported to be a very strong biosurfactant producing
strain [13]. Enhanced yield of glycoprotein (from 84 up to
960mg L1) has been achieved from Lactobacilli spp. [31].
Agricultural residues are one of the abundant and easily
accessible carbon sources for biosurfactant production,
most,however,needsomepre-treatments.Alignocellulosic
materialoftenneedsacidhydrolysisandthermaltreatment
followed by a clarifying step. Portilla-Rivera et al. [66–68]
and Paradelo et al. [71] used such media for BS production
from L. pentosus and obtained products comparable to
surfactin produced by Bacillus subtilis in terms of hydrocar-
bon emulsiﬁcation abilities and potential uses in bioreme-
diation. Paradelo et al. [71] concluded that L. pentosus grown
ongrapemarchydrolysates forBSproduction, it canreduce
thewaterrepellenceof hydrophobicmaterial,whichisvery
much better in comparison to chemical-based surfactants.
Large-scale production of biosurfactants has become
possible by the usage of hemicellulosic sugars from
vineyard pruning waste.
Other examples, where hemicellulosic sugars from
vineyard pruning waste were utilized for biosurfactant
production using Lactobacillus have been reported as
steps toward reducing environmental impact of waste
disposal [25]. Comparative studies on the kinetics of
sediment sorption on biosurfactant obtained from
L. pentosus and two chemical surfactants viz., Tween 20
and sodium dodecyl sulfate have been carried out. Their
studies showed that no sodium dodecyl sulfate is
Table 2. Summary for various raw substrates used for production of different types of biosurfactant from Lactobacilli spp.
Name of
the
organisms
Cheaper substrates used in the production
process
Type/composition of
biosurfactant (BS)
Yield of
biosurfactant References
L. pentosus
CECT-4023
Cheese whey and molasses Crude BS Pmax¼ 1.4 g L1
and rp/
X¼ 0.093 g L1
per h
[13]
L. agilis
CCUG31450
Cheese whey Glycoprotein 960mgL1 [31]
L. pentosus Grape marc after supplementation with corn
steep liquor (10 g L1) and yeast extract (10 g L1)
Intracellular BS 4.8mg L1 [66]
L. pentosus Grape marc BS 5.9 g L1 [67]
Composition not mentioned
L. pentosus • Hemicellulosic sugar hydrolyzates obtained
from trimming vine shoots
BS • 0.71 g of BS per
g of biomass
[54]
• Barley bran husk hydrolyzates Composition not mentioned • 0.28 g of BS per
g of biomass
L. pentosus • Sugars from agricultural distilled grape marc
hydrolyzates
BS Not mentioned [68]
• Low-cost feedstock agricultural residues as
substrates: hazelnut shells, distilled grape marc,
walnut shells
Protein fractions probably
associated with bound
phosphate
L. delbrueckii Peanut oil cake Glycolipid with carbohydrate
and lipid combination of
30%:70% (w/w)
5.35mgml1 [8]
L. pentosus Vineyard pruning waste Glycolipopeptide Not mentioned [25]
L. pentosus Vineyard pruning waste BS rich in protein content Ranging between
0.29 and
1.35mgL1
[50]
Note: Pmax, maximum concentration of biosurfactant (g L1); rp, initial volumetric rate of biosurfactant formation(g L1 h1).
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adsorbed onto the sediments, whereas Tween 20 and
biosurfactants from L. pentosus are absorbed after a few
minutes. In addition to agricultural waste substrates,
diary-based products have a crucial role in biosurfactant
industries. Since,most of the Lactobacillus strains used for
biosurfactant production are either isolated from dairy
based products or of human origin. Various oils have
been proved as best substrates for biosurfactants
production from genus Lactobacillus. Thavasi et al. [8]
tried to grow L. delbrueckii in peanut oil cake supple-
mented media and yielded 5.35mgml1 of biosurfac-
tant. Their studies have a great impact on demonstrating
that biosurfactants alone have the capacity to enhance
the biodegradation of crude oil up to greater extent in
absence of fertilizers. Even though biosurfactant pro-
duction from Lactobacilli spp. work has been docu-
mented in the literature since long time, inadequate
scientiﬁc reports are available on biosurfactant produc-
tion from Lactobacilli spp. using cheap and renewable
substrates. It is important to highlight that few reports
do discuss on biosurfactant production using Lactobacil-
lus spp. by using agriculture residues [71]. In spite of the
availability of huge number of renewable substrates,
hardly any work has been investigated on this aspect.
Biosurfactant derived from lactic acid bacteria has
tremendous scope in industrial sectors and therefore,
need to explore on broader scale [72].
Future prospects
Lactobacilli produced biosurfactants appear to have
great biomedical potential applications. In the ﬁeld of
biosurfactants and related production technology, we
are actively in search of novel strains capable of utilizing
cheaper, renewable substrates, greater yields, and novel
applications. Several numbers of industries are vigor-
ously seeking suitable surface active molecules with
advanced applications. Huge possible opportunities are
available today in this ﬁeld for designing new biosur-
factant-based formulationswhichmay have highmarket
demand. The composition of most of the biosurfactants
has not been fully elucidated. The diverse competence of
biosurfactants produced by probiotic bacteria toward
therapeutic approaches can be highly signiﬁcant. It has
been suggested that utilizing these surface active
molecules in preventing and/or dealing with hospital-
acquired infections may be an important undertaking.
Other promising applications include inhibiting micro-
bial bioﬁlm formation and the prevention of urogenital
infection in mammals in addition to use as an adjuvants
to conventional antibiotics in the treatment of hospital-
acquired diseases or infections. This needs much more
attention so that those surface active molecules can be
utilized for several applications in diverse ﬁelds.
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